Clinical Trial Update: Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating azacitidine in newly diagnosed acute myeloid leukemia patients who are elderly and not eligible for standard induction therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Kansas City Veteran Affairs Medical Center | Conditions: Acute Myeloid Leukemia, Elderly | Phase 2 | Status: UNKNOWN